Lifestyle Medicine for Enhancing Psychological Wellness in Police Officers
1 other identifier
interventional
40
1 country
1
Brief Summary
This study will examine the feasibility and efficacy of lifestyle medicine for the enhancement of psychological wellness in police officers. The integrative lifestyle intervention is based on the "Healthy Body Healthy Mind (HBHM)" programme developed by the University of Melbourne. It includes lifestyle psychoeducation, physical activity, nutrition and diet, relaxation/ mindfulness, and sleep. These components are weaved with psychological elements such as stress management, cognitive restructuring, motivational interviewing, and goal setting strategies that are led by clinical psychologists. While lifestyle medicine has been recognised for centuries a a mean to improve physical health, the field of lifestyle medicine in the context of mental health is still in its infancy. Nevertheless, there is increasing evidence demonstrating the efficacy of individual components of lifestyle medicine (e.g. diet, physical activities, and sleep) on mood and stress management. With a well-researched lifestyle medicine programme adopted from Australia, the research team of the Chinese University of Hong Kong has customised the intervention protocol to fit the Chinese culture, and has conducted a pilot trial to test the protocol across different communities and work populations. The investigators aim to examine the effectiveness of an integration of multiple lifestyle adjustments on psychological wellness from a holistic body-mind perspective. Acknowledging that police officers are one of hte work populations with stressful work nature, it is in a hope that lifestyle medicine would be effective to facilitate stress coping and enhance the psychological wellness of police officers in the long run.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2019
CompletedFirst Posted
Study publicly available on registry
April 24, 2019
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedMarch 11, 2020
March 1, 2020
6 months
April 22, 2019
March 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the Patient Health Questionnaire (PHQ-9)
The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day). PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe and severe depression respectively.
Baseline, 1-week post-treatment and 12-week post treatment
Secondary Outcomes (8)
Change in Depression Anxiety Stress Scales (DASS-21)
Baseline, 1-week post-treatment and 12-week post treatment
Change in Insomnia Severity Index (ISI)
Baseline, 1-week post-treatment and 12-week post treatment
Brief Resilience Scale
Baseline, 1-week post-treatment and 12-week post treatment
Short Form (Six-Dimension) Health Survey (SF-6D)
Baseline, 1-week post-treatment and 12-week post treatment
Health-Promoting Lifestyle Profile (HPLP II)
Baseline, 1-week post-treatment and 12-week post treatment
- +3 more secondary outcomes
Study Arms (2)
Treatment Group
EXPERIMENTALLifestyle Medicine Group 1
Waitlist Control Group
EXPERIMENTALLifestyle Medicine Group 2
Interventions
diet, sleep, exercise and mindfulness
Eligibility Criteria
You may qualify if:
- Hong Kong residents aged ≥ 18 years;
- Cantonese language fluency;
- Patient Health Questionnaire (PHQ-9) score ≥ 10; and
- Willingness to provide informed consent and comply with the trial protocol.
You may not qualify if:
- Pregnancy;
- Have suicidal ideation with PHQ-9 item 9 score ≥ 2 (referral information to professional services will be provided to those who endorsed items on suicidal ideation);
- Using medication or psychotherapy for depression;
- Having unsafe conditions and are not recommended for exercising or a change in diet by physicians; and
- Have major psychiatric, medical or neurocognitive disorders that make participation infeasible or interfere with the adherence to the lifestyle intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chinese University of Hong Konglead
- University of Melbournecollaborator
- University of Western Sydneycollaborator
Study Sites (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 22, 2019
First Posted
April 24, 2019
Study Start
June 1, 2019
Primary Completion
November 30, 2019
Study Completion
December 31, 2019
Last Updated
March 11, 2020
Record last verified: 2020-03